Medison introduces two new ultrasound systems

Article

The Medison SonoAce 9900 is a fully digital Windows NT 2000-based ultrasound system with multispecialty applications in general imaging, ob/gyn, perinatology, cardiology, vascular, small parts, musculoskeletal, and urology. Medison of Cypress, CA,

The Medison SonoAce 9900 is a fully digital Windows NT 2000-based ultrasound system with multispecialty applications in general imaging, ob/gyn, perinatology, cardiology, vascular, small parts, musculoskeletal, and urology.

Medison of Cypress, CA, introduced the new system at this month’s Federation of International Gynecology and Obstetrics (FIGO) meeting in Washington, DC.

The SonoAce 9900 incorporates digital multibeam signal processing supporting phased-sector, curved, endovaginal, and linear array transducers. The transducer frequency range is from 1 MHz to 12 MHz. The system includes M-Mode, color Doppler, pulsed and continuous-wave Doppler, and power Doppler capabilities.

Digital 3-D imaging offers multibeam signal processing capability allowing 3-D in such applications as power Doppler and multiplanar imaging. The SonoAce 9900 includes the 3-D volume quantification method, Virtual Organ Computer Aided Analysis (VOCAL), to assess the volume of anatomical structures and masses.

Medison’s Voluson 730 ultrasound system is a premium high-end, fully digital Windows NT 2000-based ultrasound system that will replace the Voluson 530D. The new system’s digital platform is designed to expand current technologies and the possibilities for future applications. The 2000 digital platform offers capabilities for enhancing tissue information display; an increased frame rate, to define fast-moving structures; and the first real-time 4-D volume imaging, for higher quality results and a significant increase in available diagnostic information.

The Voluson 730 provides true real-time volume data acquisition to image fetal movement without any artifacts or loss of information. The system also offers 3-D volume quantification, advanced harmonic imaging, a quad digital beamformer, and online remote diagnostics. FDA clearance is pending.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.